The page cannot be displayed because you are using Internet Explorer version 8 or lower.

Please consider upgrading your browser here

We use cookies on this website. By using the website you accept our use of cookies. Accept

 
 
 
 

Investigator Initiated Clinical Trials

Grant capital: 
From DKK 5 to 20 million per project over a project period of 3-5-years
Total grant capital in 2018 is DKK 60 million

 

Application form:
Will be open from February 19, 2018

 

Application deadlines
June 13, 2018, 2pm
 

Decision announcements
Mid-December, 2018

 

The earliest project start date
January 1, 2019

(The grant cannot be activated until all approvals from the relevant public authorities have been obtained)

 

The latest project start date
November 30, 2019

Committee on Clinical and Translational Medicine

Lars Fugger, Jens Otto Lunde Jørgensen, Gedske Daugaard, Jan Gerstoft, Jørgen Frøkiær, Henrik Toft Sørensen, Lars Køber, Claus Nerlov

Link to committee

THIS CALL RELATES TO 2017, THE CALL WILL BE REVISED IN FEBRUARY 2018. 

AIM

The purpose of the program is to strengthen the opportunities to carry out larger randomized clinical trials in Denmark. The ultimate goal is to improve the treatment of patients through new medicine and new technology and to ensure the highest quality in treatment.

 

ELIGIBILITY

  • Grants are available for both national and international multicenter clinical trials, as long as the coordinating investigator (main applicant) is anchored in Denmark. For international studies anchored outside Denmark, the grant can cover only the part of the project carried out in Denmark.
  • Main applicant (Investigator) must be a specialist physician employed at the hospital where the project is anchored.
  • All aspects of the clinical trial must be fully transparent, and when the clinical trial ends, the data must be made available to other researchers in a depersonalized form through public databases.
  • An applicant can submit an application to the foundation before all legal approvals have been obtained, but the grant cannot be activated until all approvals from the relevant public authorities have been obtained. If a grant is not activated within one year following the date of the grant letter, the grant will be considered annulled.

 

Studies with an industrial/commercial focus or purpose are not eligible for support!

FUNDING

From DKK 5 to 20 million per project over a project period of 3-5 years. Total grant capital in 2017 is DKK 60 million.

 

RESEARCH FIELDS

Applications may be submitted for most types of larger clinical trials that include patients and aim to improve existing treatment routines. Examples include but are not limited to: the use of medicines, including repositioning; medical technology, including testing medical devices; treatments such as surgical procedures, radiotherapy and new advanced genetic and cell therapy methods; and therapies such as physiotherapy or other invention or rehabilitation initiatives.

 

APPLICATION PROCESS

For the full description of eligibility and requirements for the application please thoroughly read: ”Information and guidelines for applicants – Investigator Initiated Clinical Trials 2017”.

 

The application must be submitted in English.

 

Contact

Ursula Bach

Grant Administrator

Tlf.: +45 3527 6609

Email: urba@novo.dk